Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 4366 (2023-2024)

https://ontology.bommaritollc.com/id/01a0d568-8f9a-71fb-9f4d-032c917c1116

adms:identifier	mi-legislature-measure 2023-2024/HB/4366
dcterms:temporal	Michigan Legislature, 2023-2024 session
primary sponsor	Curtis S VanderWall
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4366 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4366 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4366
schema:legislationChanges	MCL 15.677 MCL 15.673
schema:legislationIdentifier	HB 4366
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106. TIE BAR WITH: HB 4365'23en
schema:sponsor	Jennifer Conlin Joseph A. Aragona Brian BeGole Pat Outman Curtis S VanderWall Jim Haadsma Robert Bezotte
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2023-HB-4366
skos:prefLabel	HB 4366 (2023-2024)en
status	in committee
status date	2023-04-11xsd:date